Literature DB >> 3283131

Isolation of insulin degradation products from endosomes derived from intact rat liver.

F G Hamel1, B I Posner, J J Bergeron, B H Frank, W C Duckworth.   

Abstract

Rats were injected with [125I]iodoinsulin labeled at either the A14 or B26 tyrosine, and the animals were killed and livers subcellularly fractionated to yield light (early or neutral) endosomes and heavy (late or acidic) endosomes. 125I-Labeled material was extracted from endosomes and analyzed by Sephadex G-50 filtration and high performance liquid chromatography (HPLC). Radiolabeled material in both types of endosomes is comprised of high molecular weight, insulin-sized, and low molecular weight components, with B chain-labeled small molecular weight material in two peaks, one corresponding to iodotyrosine and one to small peptides (Mr less than 1500). As compared with A chain label, however, less of the B chain material appears in the degradation components (both high and low molecular weight fractions) suggesting that a fragment of B chain containing the B26 residue is lost from the endosomes. Analysis on HPLC shows that significant amounts of the insulin-sized and high molecular weight material have proteolytic cleavage(s) in the B chain with an intact A chain. The B chain-derived labeled peptides elute from HPLC identically with products generated by insulin protease. These results therefore show substantial insulin degradation occurring in light endosomes prior to endosomal acidification and to receptor dissociation, suggesting receptor-bound insulin is a substrate for insulin protease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3283131

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization.

Authors:  V Chesneau; K Vekrellis; M R Rosner; D J Selkoe
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  Intracellular degradation by liver endothelial cells.

Authors:  S Misquith; S Wattiaux-De Coninck; R Wattiaux
Journal:  Mol Cell Biochem       Date:  1989 Nov 23-Dec 19       Impact factor: 3.396

3.  Fate of injected glucagon taken up by rat liver in vivo. Degradation of internalized ligand in the endosomal compartment.

Authors:  F Authier; M Janicot; F Lederer; B Desbuquois
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

4.  Receptor-recycling model of clearance and distribution of insulin in the perfused mouse liver.

Authors:  H Sato; T Terasaki; H Mizuguchi; K Okumura; A Tsuji
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

Review 5.  Physiological functions of endosomal proteolysis.

Authors:  T Berg; T Gjøen; O Bakke
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

6.  Identification of glutamate-169 as the third zinc-binding residue in proteinase III, a member of the family of insulin-degrading enzymes.

Authors:  A B Becker; R A Roth
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

7.  Inositol phosphates and phosphoinositides activate insulin-degrading enzyme, while phosphoinositides also mediate binding to endosomes.

Authors:  Eun Suk Song; HyeIn Jang; Hou-Fu Guo; Maria A Juliano; Luiz Juliano; Andrew J Morris; Emilia Galperin; David W Rodgers; Louis B Hersh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-21       Impact factor: 11.205

Review 8.  Insulin Signalling: The Inside Story.

Authors:  Barry I Posner
Journal:  Can J Diabetes       Date:  2016-09-07       Impact factor: 4.190

9.  Characterization of macrophage sensitivity and resistance to anthrax lethal toxin.

Authors:  A M Friedlander; R Bhatnagar; S H Leppla; L Johnson; Y Singh
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

10.  Purification of a protease in red blood cells that degrades oxidatively damaged haemoglobin.

Authors:  J M Fagan; L Waxman
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.